---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000733"
form_type: "8-K"
ticker: "MITI"
cik: "0000802257"
company_name: "Mitesco, Inc."
filed_at: "2023-07-19T23:59:59+00:00"
generated_at: "2026-06-13T06:43:37.850506+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Mitesco appoints Allen Plunk to Board of Directors, with emphasis on healthcare tech acquisitions

## Summary
- Allen Plunk appointed to Mitesco Board effective July 17, 2023.
- Plunk is Senior VP & Divisional GM at NextGen Healthcare (NASDAQ:NXGN); 15 years in healthcare tech.
- Company prioritizes evaluating acquisitions of healthcare technology and services entities.
- CEO notes Plunk's expertise in finance and operations to aid turnaround and acquisition strategy.

## SEC filing metadata
- accession: 0001185185-23-000733
- form_type: 8-K
- ticker: MITI
- cik: 0000802257
- company_name: Mitesco, Inc.
- filed_at: 2023-07-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/802257/000118518523000733/0001185185-23-000733-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/802257/000118518523000733/mitesco20230718_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000733
- JSON: https://secwatch.observer/filing/0001185185-23-000733.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000733.txt

## Key facts
- Executive change
  Allen Plunk was appointed as Director at Mitesco, Inc..
  - Action: appointed
  - Role: Director
  source text: On July 17, 2023, Mr. Allen Plunk was appointed to the Board of Directors of Mitesco, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/802257/000118518523000733/0001185185-23-000733-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.